Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

European Wax Center (EWCZ) Asset Writedowns and Impairment (2020 - 2025)

Historic Asset Writedowns and Impairment for European Wax Center (EWCZ) over the last 6 years, with Q3 2025 value amounting to $2000.0.

  • European Wax Center's Asset Writedowns and Impairment fell 9807.69% to $2000.0 in Q3 2025 from the same period last year, while for Jul 2025 it was $532000.0, marking a year-over-year increase of 22839.51%. This contributed to the annual value of $570000.0 for FY2025, which is 34186.05% up from last year.
  • Per European Wax Center's latest filing, its Asset Writedowns and Impairment stood at $2000.0 for Q3 2025, which was down 9807.69% from $73000.0 recorded in Q2 2025.
  • Over the past 5 years, European Wax Center's Asset Writedowns and Impairment peaked at $301000.0 during Q2 2021, and registered a low of $2000.0 during Q3 2025.
  • For the 5-year period, European Wax Center's Asset Writedowns and Impairment averaged around $97733.3, with its median value being $61000.0 (2023).
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first soared by 102000.0% in 2024, then plummeted by 9807.69% in 2025.
  • Over the past 5 years, European Wax Center's Asset Writedowns and Impairment (Quarter) stood at $211000.0 in 2021, then tumbled by 81.99% to $38000.0 in 2022, then plummeted by 34.21% to $25000.0 in 2023, then surged by 1020.0% to $280000.0 in 2024, then plummeted by 99.29% to $2000.0 in 2025.
  • Its Asset Writedowns and Impairment stands at $2000.0 for Q3 2025, versus $73000.0 for Q2 2025 and $177000.0 for Q1 2025.